Osteoporosis Treatment Market Focusing On Companies, Development, Challenges, Growth, Revenue & Forecast 2028

Market Overview:

The global osteoporosis treatment market was valued at USD 12.61 billion in 2021 and is expected to reach USD 17.39 billion by the year 2028, at a CAGR of 4.7%.

Osteoporosis is a bone disease characterized by loss of bone density and quality and that occurs with age. Osteoporosis results in broken bones in the wrist, hip, and spine, and it is caused due to various factors which include low intake of calcium magnesium, and vitamin D, genetic factors, excessive alcohol intake eating disorders such as anorexia, inactivity, and immobility. Cancer, chronic obstructive pulmonary disease, chronic kidney diseases, and other autoimmune diseases can increase the risk of osteoporosis which can support for market growth.

Read Full Research Report: -
https://introspectivemarketresearch.com/reports/osteoporosis-treatment-market/

Market Dynamics:

Driver:

The increasing prevalence and incidence of osteoporosis in recent years. For instance, in accordance with the International Osteoporosis Foundation, osteoporosis causes over 8.9 billion fractures annually around the world, resulting in an osteoporosis fracture every 3 seconds. With the growing number of hip fractures, vertebral fractures, and other severe fractures, people are becoming more about osteoporosis treatment. In addition to this, a growing number of people are suffering from calcium deficiency, especially the women population. Osteoporosis disease is caused due to the law of physical activity and the IT sector's working population has low levels of physical activity and the working population among the IT sector. These factors can increase the market for osteoporosis treatment.

Opportunities:

The growing approvals and launches of new osteoporosis drugs provide a lucrative opportunity for osteoporosis treatment market growth over the forecast period. The research and development activities are increasing and increasing the initiative of the government as well as private organizations in the healthcare sectors. The key players focus to the provides top-class medications to these individuals at an affordable rate due to the increasing prevalence of osteoporosis which offers the opportunity for the market in the forthcoming year.

Acquire PDF Sample Report + All Related thorough TOC, Graphs and Tables of Global Osteoporosis Treatment Market Now:
https://introspectivemarketresearch.com/inquiry/16088

Market coverage

•Available market numbers - 2022-2028
•Base Year - 2021
•Forecast Period - 2022-2028
•Segments covered - By Drug Class, By Route of Administration.
•Competitive Landscape - Amgen Inc. (US),F. Hoffmann-La Roche AG (Switzerland),Radius Health Inc. (the US),Merck & Co. Inc. (US)

Market Segmentation

By Drug Class

• Bisphosphonates
• Parathyroid Hormone Therapy
• Rank Ligand Inhibitors
• Others

By Route of Administration

• Oral
• Injectable
• Others

For More Information or Query or, Customization before Buying Visit:
https://introspectivemarketresearch.com/inquiry/16088

By Region

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
• Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
• South America (Brazil, Argentina, Rest of South America)

Major Key Players Considered in the Market

• Amgen Inc. (US)
• F. Hoffmann-La Roche AG (Switzerland)
• Radius Health Inc. (the US)
• Merck & Co. Inc. (US)
• Novartis International AG (Switzerland)
• Pfizer Inc. (US)
• Sun Pharmaceutical Industries Ltd. (India)
• Takeda Pharmaceutical Company Limited (Japan)
• Teva Pharmaceutical Industries Ltd (Israel)
• Allergan Plc (Ireland)
• Eli Lily and Company (US) and other major players.

Up-To Avail 20% Discount on various license types on immediate purchase (Use corporate email ID). Get Higher Priority
https://introspectivemarketresearch.com/discount/16088

Recent Industry Developments in Osteoporosis Treatment Market:

In October 2021, Radius Health, Inc. announced the findings of the ATOM study, which assessed abaloparatide 80 mcg subcutaneous (SC) for usage in males with osteoporosis. The study reported favorable topline findings, for instance, patients who received abaloparatide-SC had an average rise of 8.5 percent in LS BMD, whereas those who received the placebo had an average increase of 1.2 percent.

In July 2021, Sun Pharmaceuticals got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) for the manufacturing and marketing of its Teriparatide injection in a pre-filled pen 600mcg/2.4 ml (Synthetic origin). Teriparatide is a recombinant hormone that is mainly administered for the treatment of osteoporosis in men and postmenopausal women who are at high risk of having a fracture.

Table OF Content

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
 3.1 By Drug Class
 3.2 By Route of Administration
Chapter 4: Market Landscape
Chapter 5: Osteoporosis Treatment Market by Drug Class
To Be Continued……

Buy the Latest Version of this Report @ https://introspectivemarketresearch.com/checkout/?user=1&_sid=16088

Read Related Report: -

https://introspectivemarketresearch.com/reports/orthopedic-orthotics-market/

https://introspectivemarketresearch.com/reports/asia-pacific-rehabilitation-equipment-market-comprehensive-study-report-recent-trends/

https://introspectivemarketresearch.com/reports/rehabilitation-equipment-market-global-industry-growth-and-trend-analysis/

Contact us:
Introspective Market Research
3001 S King Drive,
Chicago, Illinois
60616 USA
Ph no: +1-773-382-1047
Email : sales@introspectivemarketresearch.com

About us:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

This release was published on openPR.